In this study, we found that LGALS3 functions downstream of USP15 and is upregulated in HCC, where it can interact with USP15 to promote HCC cell stemness, proliferation, and lenvatinib resistance. The gene discussed is LGALS3; the disease is hepatocellular carcinoma.